Intravenous immunoglobulin is now used in a wide range of neurological conditions. However, side effects are relatively common, treatment is expensive and sustained benefit unusual without repeated administration. This article aims to provide clinicians with an overview of the potential benefits and drawbacks of intravenous immunoglobulin in neurological practice and concludes with suggested guidelines for its use in adults.